Comparison of daptomycin and glycopeptide efficacy and safety for the treatment of Gram-positive infections: a systematic review and meta-analysis.

MLA

Boulekbache, Abdelwahab, et al. “Comparison of Daptomycin and Glycopeptide Efficacy and Safety for the Treatment of Gram-Positive Infections: A Systematic Review and Meta-Analysis.” Journal of Antimicrobial Chemotherapy (JAC), vol. 79, no. 4, Apr. 2024, pp. 712–21. EBSCOhost, https://doi.org/10.1093/jac/dkae026.

APA

Boulekbache, A., Maldonado, F., Kavafian, R., Ferry, T., Bourguignon, L., Goutelle, S., Lega, J.-C., & Garreau, R. (2024). Comparison of daptomycin and glycopeptide efficacy and safety for the treatment of Gram-positive infections: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy (JAC), 79(4), 712–721. https://doi.org/10.1093/jac/dkae026

Chicago

Boulekbache, Abdelwahab, Fanny Maldonado, Raphael Kavafian, Tristan Ferry, Laurent Bourguignon, Sylvain Goutelle, Jean-Christophe Lega, and Romain Garreau. 2024. “Comparison of Daptomycin and Glycopeptide Efficacy and Safety for the Treatment of Gram-Positive Infections: A Systematic Review and Meta-Analysis.” Journal of Antimicrobial Chemotherapy (JAC) 79 (4): 712–21. doi:10.1093/jac/dkae026.